Amgen Inc. (AMGN) Q1 2023 Earnings Results

Amgen Beats on EPS, Stock Up 0.64%

Amgen's earnings report shows a positive surprise in EPS, which contributed to a slight increase in stock price. The lack of revenue data and guidance may leave investors cautious, but management's focus on R&D suggests a commitment to future growth. The stock's modest rise reflects a generally favorable reception to the earnings beat.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$3.98	N/A	+3.7%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management expressed a cautious optimism about future growth driven by their pipeline. They emphasized the significance of innovation in their strategy.

Management highlighted ongoing investments in R&D as a key focus.

They noted the importance of maintaining strong market positions despite competitive pressures.

Amgen Beats on EPS, Stock Up 0.64%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Up 0.64%

Key numbers

Management commentary